Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christian Rainer

Showing results (131-140 of 160) with videos related to

Pageof 16
Sort By:
British Journal of Pharmacology|June 22, 2019
Bcl-2/Bcl-xL inhibition predominantly synergistically enhances the anti-neoplastic activity of a low-dose CUSP9 repurposed drug regime against glioblastomaMarc-Eric Halatsch, Richard Eric Kast, Annika Dwucet, et al.
Neurochemical Research|August 31, 2017
Anti-glioma Activity of Dapsone and Its Enhancement by Synthetic Chemical ModificationGeorg Karpel-Massler, Richard E Kast, Markus D Siegelin, et al.
British Journal of Neurosurgery|July 25, 2013
Cognitive performance following spontaneous subarachnoid haemorrhage versus other forms of intracranial haemorrhageChristine Brand, Burkhard Alber, Anne-Katharina Fladung, et al.
Cellular Oncology (Dordrecht, Netherlands)|March 13, 2019
Combined inhibition of RAC1 and Bcl-2/Bcl-xL synergistically induces glioblastoma cell death through down-regulation of the Usp9X/Mcl-1 axisMichal Hlavac, Annika Dwucet, Richard Eric Kast, et al.
Global Spine Journal|May 14, 2025
Adjacent Segment Motion of Stand-Alone ALIF Versus TLIF in the Degenerative Spine: A Biomechanical StudyAlina Jacob, Daniel Haschtmann, Tamás F Fekete, et al.
Circulation|July 13, 2006
Early recurrent ischemic stroke in stroke patients undergoing intravenous thrombolysisDimitrios Georgiadis, Stefan Engelter, Barbara Tettenborn, et al.
Frontiers in Cell and Developmental Biology|December 13, 2021
ONC201/TIC10 Is Empowered by 2-Deoxyglucose and Causes Metabolic Reprogramming in Medulloblastoma Cells <i>in Vitro</i> Independent of C-Myc ExpressionAnnika Dwucet, Maximilian Pruss, Qiyu Cao, et al.
Neurosurgery|October 2, 2019
Surgery for Diffuse WHO Grade II Gliomas: Volumetric Analysis of a Multicenter Retrospective Cohort From the German Study Group for Intraoperative Magnetic Resonance ImagingMoritz Scherer, Hajrulla Ahmeti, Constantin Roder, et al.
Oncology Letters|October 23, 2018
Viability of glioblastoma stem cells is effectively reduced by diisothiocyanate-derived mercapturic acidsKamila Cwiklowska, Mike-Andrew Westhoff, Simon Freisinger, et al.
Oncotarget|November 3, 2016
Exogenous cathepsin G upregulates cell surface MHC class I molecules on immune and glioblastoma cellsMadleen Giese, Nadine Turiello, Nicole Molenda, et al.
Pageof 16

Showing results (131-140 of 160) with videos related to

Sort By:
Pageof 16
British Journal of Pharmacology|June 22, 2019
Bcl-2/Bcl-xL inhibition predominantly synergistically enhances the anti-neoplastic activity of a low-dose CUSP9 repurposed drug regime against glioblastomaMarc-Eric Halatsch, Richard Eric Kast, Annika Dwucet, et al.
Neurochemical Research|August 31, 2017
Anti-glioma Activity of Dapsone and Its Enhancement by Synthetic Chemical ModificationGeorg Karpel-Massler, Richard E Kast, Markus D Siegelin, et al.
British Journal of Neurosurgery|July 25, 2013
Cognitive performance following spontaneous subarachnoid haemorrhage versus other forms of intracranial haemorrhageChristine Brand, Burkhard Alber, Anne-Katharina Fladung, et al.
Cellular Oncology (Dordrecht, Netherlands)|March 13, 2019
Combined inhibition of RAC1 and Bcl-2/Bcl-xL synergistically induces glioblastoma cell death through down-regulation of the Usp9X/Mcl-1 axisMichal Hlavac, Annika Dwucet, Richard Eric Kast, et al.
Global Spine Journal|May 14, 2025
Adjacent Segment Motion of Stand-Alone ALIF Versus TLIF in the Degenerative Spine: A Biomechanical StudyAlina Jacob, Daniel Haschtmann, Tamás F Fekete, et al.
Circulation|July 13, 2006
Early recurrent ischemic stroke in stroke patients undergoing intravenous thrombolysisDimitrios Georgiadis, Stefan Engelter, Barbara Tettenborn, et al.
Frontiers in Cell and Developmental Biology|December 13, 2021
ONC201/TIC10 Is Empowered by 2-Deoxyglucose and Causes Metabolic Reprogramming in Medulloblastoma Cells <i>in Vitro</i> Independent of C-Myc ExpressionAnnika Dwucet, Maximilian Pruss, Qiyu Cao, et al.
Neurosurgery|October 2, 2019
Surgery for Diffuse WHO Grade II Gliomas: Volumetric Analysis of a Multicenter Retrospective Cohort From the German Study Group for Intraoperative Magnetic Resonance ImagingMoritz Scherer, Hajrulla Ahmeti, Constantin Roder, et al.
Oncology Letters|October 23, 2018
Viability of glioblastoma stem cells is effectively reduced by diisothiocyanate-derived mercapturic acidsKamila Cwiklowska, Mike-Andrew Westhoff, Simon Freisinger, et al.
Oncotarget|November 3, 2016
Exogenous cathepsin G upregulates cell surface MHC class I molecules on immune and glioblastoma cellsMadleen Giese, Nadine Turiello, Nicole Molenda, et al.
Pageof 16